Upcoming Challenges in Multidisciplinary Heart Failure Management: Active Role of Future Clinical Pharmacists

J Motiejunaite; T Chouihed; A Mebazaa

doi:10.1002/cpt.728

Upcoming Challenges in Multidisciplinary Heart Failure Management: Active Role of Future Clinical Pharmacists

Clin Pharmacol Ther. 2017 Aug;102(2):180-182. doi: 10.1002/cpt.728. Epub 2017 Jun 5.

Authors

J Motiejunaite^{1

2

3}, T Chouihed^{4

5}, A Mebazaa^{1

2

6}

Affiliations

¹ APHP, Saint Louis Lariboisière Hospitals, Department of Anesthesiology and Critical Care, 75010, Paris, France.
² INSERM, U942, BIOmarkers in CArdioNeuroVAScular Diseases, 75010, Paris, France.
³ Department of Cardiology, Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.
⁴ Emergency Department, University Hospital of Nancy, 54000, Nancy, France.
⁵ Université de Lorraine, Vandoeuvre-les-Nancy, France.
⁶ Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

PMID: 28581206
DOI: 10.1002/cpt.728

Abstract

In their article "Role and Value of Clinical Pharmacy in Heart Failure Management" Stough and Patterson discuss the potential benefits that clinical pharmacists could bring to heart failure management. They mostly focused on chronic stable heart failure. The objective of this commentary is to provide future perspectives for clinical pharmacist involvement in multidisciplinary heart failure team in the management of patients admitted in emergency for decompensation of their heart condition.

MeSH terms

Disease Management*
Forecasting
Heart Failure / diagnosis
Heart Failure / epidemiology
Heart Failure / therapy*
Humans
Patient Care Team / trends*
Pharmacists / trends*
Professional Role*